Back to funds
View filing
Novo Holdings A/S
hedge fundUpdated 27 days agoManaged by Novo Holdings A/S • Latest filing Q2 2026
Portfolio value
$1.7B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-6.6%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.5B |
| Q2 2023 | $1.3B |
| Q3 2023 | $1.4B |
| Q4 2023 | $1.6B |
| Q1 2024 | $1.4B |
| Q2 2024 | $1.7B |
| Q3 2024 | $2B |
| Q4 2024 | $1.7B |
| Q1 2025 | $1.3B |
| Q2 2025 | $1.4B |
| Q3 2025 | $1.6B |
| Q4 2025 | $1.3B |
| Q1 2026 | $1.2B |
| Q2 2026 | $1.7B |
Top holdings
25 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EWTX EDGEWISE THERAPEUTICS INC | $217.4M | 5.35M | 12.62% | — |
| 2 | A ASMLF ASML HOLDING N V | $188.9M | 94.9K | 10.97% | — |
| 3 | C COAG HEMAB THERAPEUTICS HLDGS INC | $153.6M | 4.18M | 8.92% | — |
| 4 | B BXDIF BROOKFIELD CORP | $149.5M | 3.50M | 8.68% | — |
| 5 | M MPLT MAPLIGHT THERAPEUTICS INC | $132.1M | 3.69M | 7.67% | — |
| 6 | M MIRM MIRUM PHARMACEUTICALS INC | $131.7M | 1.13M | 7.65% | — |
| 7 | A AVLN AVALYN PHARMACEUTICALS INC | $127.8M | 3.88M | 7.42% | — |
| 8 | C CRM SALESFORCE INC | $61.6M | 393.2K | 3.58% | — |
| 9 | ? N/A ARRIVENT BIOPHARMA INC | $52.1M | 1.50M | 3.03% | — |
| 10 | E ELVN ENLIVEN THERAPEUTICS INC | $50.8M | 1.00M | 2.95% | — |
| 11 | C CRNX CRINETICS PHARMACEUTICALS IN | $49.4M | 1.32M | 2.87% | — |
| 12 | P PHVS PHARVARIS N V | $48.4M | 1.40M | 2.81% | — |
| 13 | F FND FLOOR & DECOR HLDGS INC | $47.3M | 797.0K | 2.75% | — |
| 14 | P PCVX VAXCYTE INC | $46.5M | 800.0K | 2.70% | — |
| 15 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $43.2M | 3.25M | 2.51% | — |
| 16 | V VRDN VIRIDIAN THERAPEUTICS INC | $39.2M | 2.13M | 2.28% | — |
| 17 | C CLDX CELLDEX THERAPEUTICS INC NEW | $38.1M | 1.02M | 2.21% | — |
| 18 | A ALMS ALUMIS INC | $31M | 1.10M | 1.80% | — |
| 19 | X XENE XENON PHARMACEUTICALS INC | $29.3M | 485.4K | 1.70% | — |
| 20 | B BBAAY ALIBABA GROUP HLDG LTD | $24.7M | 257.3K | 1.43% | — |